Tofacitnib Citrate

Lus piav qhia luv luv:

API lub npe Qhov taw qhia Specification US DMF EU DMF CEP
Tofacitnib Citrate Rheumatoid mob caj dab Hauv tsev      


Product Detail

Khoom cim npe

KHOOM PLIG

Keeb kwm

Tofacitinib citrate, tseem hu ua CP-690550 citrate, yog ib qho muaj zog inhibitor ntawm janus kinase 3 (JAK3), hematopoetic cell-txheej txheem tyrosine kinase koom nrog hauv cov teeb liab transduction tswj lymphocyte ciaj sia, proliferation, sib txawv, thiab apoptosis. Qhov inhibition yog JAK3 tshwj xeeb nrog kev xaiv 1000-fold ntau dua li lwm yam tsis yog JAK tsev neeg kinases. Dhau li ntawm inhibiting JAKS (IC50 = 1 nM), tofacitinib citrate kuj inhibits janus kinase 2 (JAK2) thiab janus kinase 1 (JAK1) nrog 20- thiab 100-fold tsawg dua hauv potency feem. Txawm li cas los xij, hauv kev tshawb fawb tsis ntev los no, kev sib koom ua ke (Ki) ntawm tofacitinib citrate rau JAK1, JAK2, thiab JAK3 tau tshaj tawm tias yog 1.6 nM, 21.7 nM, thiab 6.5 nM feem.

Kev siv

Lalitha Vijayakrishnan, R. Venkataramanan thiab Palak Gulati. Kev kho mob nrog rau janus kinase inhibitor CP-690,550. Trends in Pharmacological Sciences 2011: 32 (1); 25-34 : kuv

Khoom Citation

  • 1. Panagi I, Jennings E, et al. "Salmonella Effector SteE Hloov Cov Mammalian Serine / Threonine Kinase GSK3 rau hauv Tyrosine Kinase rau Direct Macrophage Polarization." Cell Host Microbe. 2020; 27(1):41–53.e6. PIB: 31862381
  • 2. McInnes IB, Byers NL, et al. "Kev sib piv ntawm baricitinib, upadacitinib, thiab tofacitinib kho cov kev cai ntawm cytokine signaling nyob rau hauv tib neeg leukocyte subpopulations." Arthritis Res Ther. Peb Hlis 21, 2019: 183. PIB: 31375130
  • 3. Liu S, Verma M, et al. "Steroid resistance of airway type 2 innate lymphoid cells los ntawm cov neeg mob uas muaj mob hawb pob: Lub luag haujlwm ntawm thymic stromal lymphopoietin." J Allergy Clin Immunol. 2018 Jan;141(1):257-268.e6. PIB: 28433687
  • 4. Zheng, Xu, et al. "Lub 3′ UTR ntawm pseudogene CYP4Z2P txhawb qog angiogenesis hauv qog noj ntshav los ntawm kev ua raws li ceRNA rau CYP4Z1." Kev tshawb fawb thiab kev kho mob cancer mis (2015): 1-14. PIB: 25701119

Kev piav qhia

Tofacitinib citrate yog qhov ncauj muaj JAK1/2/3 inhibitor nrog IC50s ntawm 1, 20, thiab 112 nM, raws li. Tofacitinib citrate muaj cov tshuaj tua kab mob, tshuaj tua kab mob thiab tshuaj tua kab mob.

Cia

4 ° C, tiv thaiv lub teeb

* Nyob rau hauv hnyav: -80 ° C, 6 lub hlis; -20 ° C, 1 lub hlis (tiv thaiv lub teeb)

 

Cov qauv tshuaj

Tofacitnib Citrate

Cov ntaub ntawv ntsig txog Biological

Tofacitnib Citrate 2

Cov ntaub ntawv ntsig txog Biological

Tofacitnib Citrate 3

Cov ntaub ntawv ntsig txog Biological

Tofacitnib Citrate 4

Cov ntaub ntawv ntsig txog Biological

Tofacitnib Citrate 5

Cov ntaub ntawv ntsig txog Biological

Tofacitnib Citrate 6

CERTIFICATE

2018 GMP-2
GMP 201811 (captopril, thalidomide thiab lwm yam)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Tsab Ntawv-201901

QUALITY MANAGEMENT

Kev tswj kom zoo 1

Tswv yim18Quality Consistency Evaluation tej yaam num uas tau pom zoo4, thiab6tej yaam num raug tso cai.

Kev tswj kom zoo 2

Advanced thoob ntiaj teb kev tswj hwm qhov system tau tso lub hauv paus ruaj khov rau kev muag khoom.

Kev tswj kom zoo 3

Kev saib xyuas zoo khiav los ntawm tag nrho lub neej voj voog ntawm cov khoom kom ntseeg tau tias qhov zoo thiab kho cov nyhuv.

Kev tswj kom zoo 4

Pab Pawg Kev Tswj Xyuas Kev Tswj Xyuas Kev Ua Haujlwm txhawb nqa qhov kev xav tau zoo thaum lub sijhawm thov thiab sau npe.

PRODUCTION MANAGEMENT

cpf5 ua
cpf6 ua

Kauslim Countec Lub raj mis ntim kab

cpf7 ua
cpf8 ua

Taiwan CVC Lub raj mis ntim kab

cpf9 ua
cpf 10

Ltalis CAM Board Ntim Kab

cpf 11

German Fette Compacting Tshuab

cpf12 ua

Nyiv Viswill Tablet Detector

cpf14-1

DCS Control Room

PARTNER

Kev koom tes thoob ntiaj teb
Kev koom tes thoob ntiaj teb
Kev koom tes hauv tsev
Kev koom tes hauv tsev

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb